NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

9 hedge funds and large institutions have $174K invested in Northwest Biotherapeutics, Inc. Common stock in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EFG
1
Ethos Financial Group
Pennsylvania
$12.6K
2
MSAM
2
Moloney Securities Asset Management
Missouri
$120K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$120K 501,560 +1,440 +0.3%
VWA
2
VSM Wealth Advisory
Maryland
$15.7K 65,574 – –
OCG
3
Opus Capital Group
Ohio
$14K 60,150 – –
EFG
4
Ethos Financial Group
Pennsylvania
$12.6K 49,050 +25,350 +107%
WJWM
5
Williams Jones Wealth Management
New York
$6.48K 27,000 – –
KA
6
KLCM Advisors
Wisconsin
$2.4K 10,000 – –
AMG
7
Advisors Management Group
Wisconsin
$2K 10,270 – –
HFS
8
Hantz Financial Services
Michigan
$0 250 – –
CMP
9
Coston McIsaac & Partners
Maine
$0 1,000 +1,000 New